Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio.

To test the efficacy and safety of a low molecular. Weight heparin (LMWH)--Fraxiparine, for hemodialysis (HD) anticoagulation, compared with conventional heparin (H) or serum lavage without other anticoagulation (L).Prospective controlled study.Twenty-nine consecutive patients referred for dialysis...

ver descrição completa

Detalhes bibliográficos
Autor principal: Barata, J D (author)
Outros Autores: Oliveira, C (author), Bruges, M (author), Gusmão, L (author), Santana, A (author), Ponce, P (author), Simões, J (author), Freire, I (author), Crespo, F (author), da Silva, A N (author)
Formato: article
Idioma:por
Publicado em: 1992
Texto completo:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3205
País:Portugal
Oai:oai:ojs.www.actamedicaportuguesa.com:article/3205

Texto Completo

https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3205

Registos relacionados